Abstract:Introduction: A major requirement in bone tissue engineering is the persistent and robust promotion of osteogenesis, which requires sustained stimulation with osteoinductive factors, such as bone morphogenetic protein-2 (BMP-2). However, the direct application of these factors remains challenging due to their short half-life and rapid systemic clearance. Given the well demonstrated benefits of recombinant adeno-associated viral (rAAV) vector, including long-term gene transfer efficiency and relative safety, rAAV-based therapies have been developed in both basic and translational research. However, traditional ex vivo gene transduction process is time consuming and requires multiple steps of cell culture. In addition, rAAV shows inconsistent transfection efficacy in primary cells. In this study, we co-packed rAAV-BMP-2 and human bone marrow stem cells (hBMSCs) into a gelatin scaffolds through one-step visible light-based phtocorsslinking (PXL), and tested their application for bone regenerationi. We hypothesize that the concentrated and localized release of rAAV-BMP-2 from the scaffold matrix results in higher transfection efficacy and BMP-2 expression in hBMSCs seeded within the scaffolds, thus enhancing their osteogenic differentiation and bone formation upon implantation in bone defect. Methods: hBMSCs were obtained with IRB approval from total joint arthroplasty patient. The rAAV6-BMP-2 and rAAV6-GFP reporter (as control) vectors were designed and prepared using an established protocol in our laboratory. PXL was performed using 10% gelatin and 10×106 hBMSCs/ml with different amount of rAAV6-GFP. Transfection efficiency was determined by counting GFP-positive cells ratio as well as assessing cell viability. At an optimal ratio, rAAV-BMP-2 and hBMSCs were included into gelatin through PXL. At different time point, BMP-2 production and rAAV6 release kinetics were analyzed. The osteogenesis of hBMSCs was assessed at day 28 by real time PCR and histological staining. In animal study, a 0.5 cm diameter critical size of cranial bone defect model was generated in SCID mice and then the constructs described above were transplanted. Micro-CT imaging and histological staining were used to evaluate the skull bone healing process up to 6 weeks. Results: Both rAAV and hBMSCs survived during the scaffold fabrication process. 10×104 rAAV/hBMSCs was shown to be the optimal ratio in maintaining cell viability and achieving transduction efficiency. After in situ transfection within scaffolds, hBMSCs produced higher BMP-2 amount than those subjected to traditional ex vivo transduction process, and underwent robust osteogenesis as well. In animal study, micro-CT imaging results indicated that rAAV BMP-2 & hBMSCs-activated gelatin scaffolds effectively promoted bone regeneration in mice cranial bone defect, in a manner significantly superior to that of scaffolds loaded with hBMSCs/BMP-2 protein, and was remarkably compatible to scaffolds loaded with hBMSCs previously ex vivo transduced by rAAV-BMP-2. The histological staining further confirmed the efficacious bone formation from rAAV BMP-2 & hBMSCs loaded scaffold. The results shown here thus demonstrate the feasibility of combining gene and cell therapy with biomaterial engineering via a single-step fabrication and its application for the repair of bone defect.

Angiogenesis and Osteogenesis Enhanced by Bfgf Ex Vivo Gene Therapy for Bone Tissue Engineering in Reconstruction of Calvarial Defects.

Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous β-TCP ceramic scaffolds

Vascular Derived ECM Improves Therapeutic Index of BMP-2 and Drives Vascularized Bone Regeneration.

Synergistic effects of dimethyloxallyl glycine and recombinant human bone morphogenetic protein-2 on repair of critical-sized bone defects in rats

Spatiotemporal regulation of angiogenesis/osteogenesis emulating natural bone healing cascade for vascularized bone formation

[Vascularization in transplantation of gene modified tissue engineered bone for repairing bone defect]

Bone Tissue Engineering Using Bone Marrow Stromal Cells and an Injectable Sodium Alginate/gelatin Scaffold.

VEGF-Loaded Heparinised Gelatine-Hydroxyapatite-Tricalcium Phosphate Scaffold Accelerates Bone Regeneration via Enhancing Osteogenesis-Angiogenesis Coupling

Osteogenic potential and synergistic effects of growth factors delivered from a bionic composite system.

524. Injectable BMP-2 Gene-Activated Scaffold for the Repair of Mouse Cranial Bone Defect

The Effect of Angiogenesis-Based Scaffold of MesoporousBioactive Glass Nanofiber on Osteogenesis

The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation

Dual delivery of BMP-2 and bFGF from a new nano-composite scaffold, loaded with vascular stents for large-size mandibular defect regeneration

Enhanced Repair of Segmental Bone Defects of Rats with Hvegf-165 Gene-Modified Endothelial Progenitor Cells Seeded in Nanohydroxyapatite/collagen/poly(l-Lactic Acid) Scaffolds

Enhancement of Bone Formation by Genetically-Engineered Bone Marrow Stromal Cells Expressing BMP-2, VEGF and Angiopoietin-1.

Enhanced Angiogenesis and Osteogenesis in Critical Bone Defects by the Controlled Release of BMP-2 and VEGF: Implantation of Electron Beam Melting-Fabricated Porous Ti 6 Al 4 V Scaffolds Incorporating Growth Factor-Doped Fibrin Glue

Bone Marrow Stromal Cells with A Combined Expression of Bmp-2 and Vegf-165 Enhanced Bone Regeneration

Transfect Bone Marrow Stromal Cells with Pcdna3.1-Vegf to Construct Tissue Engineered Bone in Defect Repair

scCO 2 Foamed Composite Scaffolds Incorporating Bioactive Lipids Promote Vascularized Bone Regeneration Via Hif-1α Upregulation and Enhanced Type H Vessel Formation

Adenovirus-mediated Transfer of VEGF into Marrow Stromal Cells Combined with PLGA/TCP Scaffold Increases Vascularization and Promotes Bone Repair in Vivo.

Restoration of Rat Calvarial Defects by Poly(lactide-Co-glycolide)/hydroxyapatite Scaffolds Loaded with Bone Mesenchymal Stem Cells and DNA Complexes